This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version    RSS    Subscribe    Unsubscribe    Archive    Media Kit Oct. 22, 2012

Home   The Society   Meetings   Advocacy   Contact Us

 



FDA warns about fungal meningitis in transplant patient who received NECC cardioplegia solution
Forbes    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The FDA said that it had identified two transplant patients with Aspergillus fumigatus infection who received cardioplegia solution during surgery. The solution was manufactured by the New England Compounding Center, which has been at the center of a broad investigation after the death of several patients from fungal meningitis due to contaminated vials of methylprednisolone acetate injection. More



 SOCIETY NEWS


Najarian to give Hume Lecture at ASTS Winter Symposium
ASTS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The American Society of Transplant Surgeons (ASTS) and the American Foundation for Donation and Transplantation (AFDT) are delighted and honored to have John S. Najarian, MD, as the next David Hume Lecturer at the ASTS 13th Annual State of the Art Winter Symposium. ASTS and AFDT established the David Hume Lecture to share the wisdom of an honored senior surgeon, with years of experience, with today's emerging leaders in the field of transplantation. More

ABS announces new limits on exam admissibility
ASTS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The American Board of Surgery announces changes to its admissibility requirements for initial certification in general surgery and vascular surgery. In Jan. 2012, the American Board of Medical Specialties (ABMS) instituted a new policy for all 24 ABMS member boards that limits the period an individual may be eligible for initial board certification to no more than seven years following completion of training in the specialty. More

Crosswalk webinar to be held Nov. 1
ASTS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A webinar titled "Let's Talk Crosswalk: CMS Regulations and OPTN Requirements" is scheduled for Thursday, Nov. 1, 2012, from 2 to 3 p.m. EST. In response to concerns expressed by the transplant community, CMS, HRSA, and the OPTN Contractor began an in-depth process to review and compare the requirements laid out in the OPTN Bylaws and Policies and those in the CMS Conditions of Participation for Transplant Programs. To date, this effort has focused on developing a crosswalk of the OPTN and CMS requirements and the corresponding survey and oversight processes with particular attention on how to better coordinate and align those processes. More


 TOP NEWS


Nobel economists' big impact: Kidney transplants
CNNMoney    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Economists whose work has led to nearly 2,000 kidney transplants across the United States have received their profession's ultimate international honor. Alvin E. Roth of Harvard University and Lloyd S. Shapley of the University of California at Los Angeles were named recipients of the 2012 Nobel Prize for economics at a news conference in Stockholm, Sweden. Roth and Shapley were honored for "the theory of stable allocations and the practice of market design," according to a statement from The Royal Swedish Academy of Scientists. More



Clinical trial to study immunosuppressant tacrolimus against generics
News-Medical    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Study leader to present tacrolimus grant to the Food and Drug Administration, American Society of Transplantation and American Society of Transplant Surgeons Monday, Oct. 22, in Washington, D.C. More

More HIV-positive patients receive organ transplants
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Hospitals are increasingly willing to transplant vital and scarce organs into people who have HIV, a once-unthinkable step now made possible with drug regimens that are helping such patients live longer. Most procedures have involved kidneys and livers, but a small number of centers are transplanting hearts. More

Is it safe to withdraw steroids within 7 days of renal transplantation?
Clinical Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Literature searches for all randomized controlled trials comparing VESW with steroid maintenance regimens were performed using MEDLINE, EMBASE and the Cochrane Library. Quality assessment was performed in each trial. Meta-analyses were performed to demonstrate the pooled effects of relative risk (RR) and weighted mean difference with 95 percent confidence intervals (CI). More

NORA, Organ Recovery Transportation Specialists

NORA, the Nationwide Organ Recovery Transport Alliance can help your OPO or Transplant Center! NORA services are tailored to serve all of your organization's transportation needs. Whether by Air, Ground, Local or Long Distance, one call to NORA does it all! Click here for the full story.


Factors affecting long-term renal graft survival
Renal & Urology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Renal transplant patients who are female, younger, or receive a kidney from a living-related donor are significantly more likely to have a functioning renal allograft at 20 years, a study found. Absence of acute rejection also is associated with such long-term allograft survival. More

Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: A meta-analysis
Liver Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Because of the severe organ shortage, living donor liver transplantation (LDLT) offers a timely alternative to deceased donor liver transplantation (DDLT) for patients with hepatocellular carcinoma (HCC). However, the higher recurrence rate of HCC after LDLT and the indication criteria remain controversial. More

Early post-transplant hospital readmission factors identified
Renal & Urology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Older kidney transplant recipients and those of African-American race are at significantly higher risk of early hospital readmission (EHR) after transplantation, a study found. In addition, EHR, defined as at least one hospital readmission to an acute care hospital within 30 days after discharge from initial kidney transplant, was significantly more likely among recipients of expanded criteria donor (ECD) kidneys, obese patients, those with diabetes or other comorbidities and those who had a longer initial hospital length of stay. More


Guidry & East

Guidry & East is a transplant consulting firm specializing in Transplant business solutions, Transplant financial and operations, along with the Medicare Organ Acquisition Cost Report.
MORE
Advertise here!

To find out how to feature your company in the ASTS Newsbrief and other advertising opportunities, Contact James DeBois at 469-420-2618
MORE


Virginia man who got historic full face transplant making an amazing recovery
New York Daily News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Seven months after receiving a full face transplant, Richard Lee Norris can go out in public without getting a second look. Norris, 37, is now able to smell and taste, the University of Maryland Medical Center said in an update on his recovery. He can also smile again. More

Drug class linked to worse outcomes after transplant
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Kidney transplant patients who receive mammalian target of rapamycin (mTOR) inhibitors after transplant have a greater probability of death or transplant failure than patients receiving calcineurin inhibitors, according to a study published online Oct. 1 in the American Journal of Transplantation. More

Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients
Clinical Transplantation (subscription required)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Delayed graft function (DGF) complicates kidney allograft outcomes in the immediate post-transplantation period. We hypothesized that in hemodialysis patients more severe anemia, iron deficiency, the requirement for higher doses of erythropoietin-stimulating agents (ESA), or blood transfusions prior to transplantation are associated with higher risk of DGF. More

Single gene variant may affect transplanted kidney survival
Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
When a patient in need of a kidney transplant finally receives their new organ, their health problems may not necessarily be over. For some kidney recipients, their bodies may ultimately reject the foreign kidney – leading to the organ's removal and another long wait for a new donor. However, new research out of the Queen Elizabeth Hospital Birmingham in the U.K. may help prevent this kind of painful rejection in the future. Scientists have discovered a single gene variant in kidney transplant donors that may predict whether or not the transplanted kidney will survive in the recipient. More
 

ASTS NewsBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Tammy Gibson, Content Editor, 469.420.2677   
Contribute news

This edition of the ASTS NewsBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Oct. 22, 2012
Oct. 8, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063